0000904454-14-000418.txt : 20140507
0000904454-14-000418.hdr.sgml : 20140507
20140507150718
ACCESSION NUMBER: 0000904454-14-000418
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140507
FILED AS OF DATE: 20140507
DATE AS OF CHANGE: 20140507
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc.
CENTRAL INDEX KEY: 0001341235
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
BUSINESS PHONE: 617-513-9882
MAIL ADDRESS:
STREET 1: 15 NEW ENGLAND EXECUTIVE PARK
CITY: BURLINGTON
STATE: MA
ZIP: 01803
FORMER COMPANY:
FORMER CONFORMED NAME: Aldexa Therapeutics, Inc.
DATE OF NAME CHANGE: 20130102
FORMER COMPANY:
FORMER CONFORMED NAME: Neuron Systems Inc
DATE OF NAME CHANGE: 20051012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TREU JESSE I
CENTRAL INDEX KEY: 0001013425
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36332
FILM NUMBER: 14820588
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-05-07
0001341235
Aldeyra Therapeutics, Inc.
ALDX
0001013425
TREU JESSE I
C/O DOMAIN ASSOCIATES, LLC
ONE PALMER SQUARE
PRINCETON
NJ
08542
1
0
1
0
Stock Option (right to buy)
8.00
2014-05-07
4
A
0
12166
0
A
2024-05-06
Common Stock
12166
12166
D
The option is exercisable in equal annual installments over three years of the Reporting Person's continuous service to the Issuer after May 7, 2014, the closing date of the Issuer's initial public offering.
Kathleen K. Schoemaker, Attorney-in-Fact
2014-05-07